288 related articles for article (PubMed ID: 30909080)
21. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
[TBL] [Abstract][Full Text] [Related]
22. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
Sun S; Cui Z; Yan T; Wu J; Liu Z
Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
[TBL] [Abstract][Full Text] [Related]
23. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
[TBL] [Abstract][Full Text] [Related]
24. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
25. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
Li P; Xiao LY; Tan H
Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
[TBL] [Abstract][Full Text] [Related]
26. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
27. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
29. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma.
Zhu L; Shen Y; Sun W
Biomed Pharmacother; 2017 Jan; 85():712-717. PubMed ID: 27923688
[TBL] [Abstract][Full Text] [Related]
30. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
[TBL] [Abstract][Full Text] [Related]
31. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
[TBL] [Abstract][Full Text] [Related]
32. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
Sun M; Shen Z
Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
[TBL] [Abstract][Full Text] [Related]
34. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
[TBL] [Abstract][Full Text] [Related]
35. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
36. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
[TBL] [Abstract][Full Text] [Related]
37. [Integrin α5 silencing inhibits proliferation, invasion and metastasis of human liver cancer Bel-7404 cells
Guo Y; Xu G; Shan M; Yang S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):893-898. PubMed ID: 32895194
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
Yan T; Ye XX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
[TBL] [Abstract][Full Text] [Related]
39. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
40. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
Lu Y; Lin J; Duan M; Rui Y; Zheng H; Zhu L; Zhu X; Wei J
Anal Cell Pathol (Amst); 2021; 2021():5228713. PubMed ID: 34926131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
